Guardant Health
GH
#1671
Rank
C$17.48 B
Marketcap
C$134.63
Share price
-7.34%
Change (1 day)
97.58%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): C-$4.52

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is C-$4.39. In 2024 the company made an earnings per share (EPS) of C-$4.87 an increase over its 2023 EPS that were of C-$5.86.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$4.52-7.27%
2024C-$4.87-16.82%
2023C-$5.86-33.13%
2022C-$8.7660%
2021C-$5.4855.04%
2020C-$3.53207.14%
2019C-$1.15-19.81%
2018C-$1.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
C-$3.79-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C-$2.93-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA